3 Asian Stocks Estimated To Be Up To 44.5% Below Intrinsic Value

Simply Wall St.03-27

In the current landscape, Asian markets are navigating through heightened geopolitical tensions and fluctuating energy prices, contributing to a complex economic environment. Amidst these challenges, ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2622576813?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","is_english":true,"pubTime":"2026-03-27 06:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2622576813","market":"hk","top_or_hot":-1,"title":"3 Asian Stocks Estimated To Be Up To 44.5% Below Intrinsic Value","media":"Simply Wall St.","content":"<div>\n<p>In the current landscape, Asian markets are navigating through heightened geopolitical tensions and fluctuating energy prices, contributing to a complex economic environment. Amidst these challenges, ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/3-asian-stocks-estimated-to-be-up-to-445-below-intrinsic-val\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Asian Stocks Estimated To Be Up To 44.5% Below Intrinsic Value</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Asian Stocks Estimated To Be Up To 44.5% Below Intrinsic Value\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-27 06:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/3-asian-stocks-estimated-to-be-up-to-445-below-intrinsic-val><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In the current landscape, Asian markets are navigating through heightened geopolitical tensions and fluctuating energy prices, contributing to a complex economic environment. Amidst these challenges, ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/3-asian-stocks-estimated-to-be-up-to-445-below-intrinsic-val\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B5MMRT66.SGD","symbol_name":"NEUBERGER BERMAN CHINA EQUITY \"A\" (SGDHDG) ACC","start_time":0,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/3-asian-stocks-estimated-to-be-up-to-445-below-intrinsic-val","article_id":"2622576813","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/3-asian-stocks-estimated-to-be-up-to-445-below-intrinsic-val","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2622576813","pubTimestamp":1774562677,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"In the current landscape, Asian markets are navigating through heightened geopolitical tensions and fluctuating energy prices, contributing to a complex economic environment. Amidst these challenges, identifying undervalued stocks can offer potential opportunities for investors seeking value in a turbulent market. Recognizing stocks trading below their intrinsic value may provide an edge in capitalizing on long-term growth prospects despite short-term uncertainties.","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B5MMRT66.SGD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (SGDHDG) ACC","LU0561508036.HKD":"ALLIANZ CHINA EQUITY \"A\" (HKD) INC","LU2476274720.SGD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"AT\" (SGDHDG) ACC","LU0348766576.USD":"ALLIANZ LITTLE DRAGONS \"A\" (USD) INC","LU0417516571.SGD":"Allianz Oriental Income Cl AT Acc SGD","LU0348767384.USD":"ALLIANZLITTLE DRAGONS \"A\" (USD) ACC","LU2399975544.HKD":"ALLIANZ ALL CHINA EQUITY \"AT\" (HKD) ACC","LU0417516738.SGD":"Allianz Hong Kong Equity AT Acc SGD","IE00BPRC5H50.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) INC","LU0348735423.USD":"ALLIANZ HONG KONG EQUITY \"A\" (USD) INC","LU0348827113.USD":"ALLIANZ RCM CHINA \"AT\" ACC","BK1161":"生物科技","IE00B543WZ88.USD":"NEUBERGER BERMAN CHINA EQUITY \"A\" (USD) ACC","LU0540923850.HKD":"ALLIANZ HONG KONG EQUITY \"A\" (HKD) INC","LU1720050803.USD":"安联全方位中国股票基金","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","LU0634319403.HKD":"ALLIANZ HONG KONG EQUITY \"AT\" (HKD) ACC","09926":"康方生物","LU1961090484.USD":"ALLIANZ ALL CHINA EQUITY \"A\" (USD) INC","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","LU0348783233.USD":"安联东方收入型 CI A Dis美元","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU2476274308.USD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"AT\" (USD) ACC","BK1574":"生物医药B类股","LU0348784397.USD":"ALLIANZ ORIENTAL INCOME \"A\" (USD) ACC","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","LU2778985437.USD":"ALLIANZ CHINA FUTURE TECHNOLOGIES \"A\" (USD) INC"},"translate_title":"3只亚洲股票估计比内在价值低44.5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09926":0.9},"content_text":"In the current landscape, Asian markets are navigating through heightened geopolitical tensions and fluctuating energy prices, contributing to a complex economic environment. Amidst these challenges, identifying undervalued stocks can offer potential opportunities for investors seeking value in a turbulent market. Recognizing stocks trading below their intrinsic value may provide an edge in capitalizing on long-term growth prospects despite short-term uncertainties.AdvertisementTop 10 Undervalued Stocks Based On Cash Flows In AsiaNameCurrent PriceFair Value (Est)Discount (Est)Tfe (KOSDAQ:A425420)₩65300.00₩128111.4849%STI (KOSDAQ:A039440)₩30850.00₩61288.3749.7%Samyang Foods (KOSE:A003230)₩1188000.00₩2353368.9049.5%Rayhoo Motor DiesLtd (SZSE:002997)CN¥29.93CN¥59.0249.3%Qyuns Therapeutics (SEHK:2509)HK$18.91HK$36.6648.4%Premium Group (TSE:7199)¥1685.00¥3300.1848.9%Maguro Group (SET:MAGURO)THB19.50THB38.0648.8%Livero (TSE:9245)¥2249.00¥4430.9549.2%Helens International Holdings (SEHK:9869)HK$0.90HK$1.7949.8%Chongqing Zaisheng Technology (SHSE:603601)CN¥13.44CN¥26.6849.6%Click here to see the full list of 228 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.Here's a peek at a few of the choices from the screener.Akeso (SEHK:9926)Overview: Akeso, Inc. is a biopharmaceutical company involved in the research, development, manufacture, and commercialization of antibody drugs globally with a market cap of HK$113.95 billion.Operations: The company's revenue is derived from the research, development, production, and sale of biopharmaceutical products, amounting to CN¥2.51 billion.Estimated Discount To Fair Value: 44.5%Akeso's stock is trading at HK$123.7, significantly undervalued compared to its estimated future cash flow value of HK$223.03, suggesting a potential opportunity for investors focused on cash flows. The company is expected to become profitable within three years with revenue growth projected at 30.3% annually, surpassing the Hong Kong market average. Despite reporting a net loss of CNY 1,113.03 million in 2025, Akeso's robust pipeline and strategic advancements in innovative drug development underpin its long-term growth potential.Our expertly prepared growth report on Akeso implies its future financial outlook may be stronger than recent results.Navigate through the intricacies of Akeso with our comprehensive financial health report here.SEHK:9926 Discounted Cash Flow as at Mar 2026Ajinomoto (TSE:2802)Overview: Ajinomoto Co., Inc. operates in the seasonings and foods, frozen foods, and healthcare sectors both in Japan and internationally, with a market cap of ¥4.33 trillion.Operations: The company's revenue is primarily derived from its Seasonings and Foods segment at ¥922.36 billion, followed by Healthcare and Others at ¥334.52 billion, and Frozen Food at ¥288.25 billion.Estimated Discount To Fair Value: 16.9%Ajinomoto, trading at ¥4,514, appears undervalued relative to its estimated future cash flow value of ¥5,432.15. Its earnings are projected to grow 17.6% annually, outpacing the Japanese market average of 9.9%. Despite high debt levels and recent share price volatility, Ajinomoto revised its profit guidance upwards due to gains from asset sales and improved business performance in certain segments. Recent executive changes may further influence strategic direction and operational efficiency.According our earnings growth report, there's an indication that Ajinomoto might be ready to expand.Get an in-depth perspective on Ajinomoto's balance sheet by reading our health report here.TSE:2802 Discounted Cash Flow as at Mar 2026Lotes (TWSE:3533)Overview: Lotes Co., Ltd. designs, manufactures, and sells electronic interconnect and hardware components in Taiwan, Mainland China, and internationally, with a market cap of NT$254.09 billion.Operations: The company's revenue primarily comes from its Electronic Components & Parts segment, totaling NT$33.78 billion.Estimated Discount To Fair Value: 42.5%Lotes is trading at NT$2,270, significantly below its estimated future cash flow value of NT$3,946.06. Despite recent earnings declines with net income at TWD 7,866 million for 2025 compared to TWD 9,276.95 million the previous year, its earnings are forecast to grow significantly by over 20% annually. However, revenue growth is expected to lag behind the Taiwan market slightly. The stock remains highly volatile but presents a compelling valuation based on discounted cash flows.Our growth report here indicates Lotes may be poised for an improving outlook.Click here and access our complete balance sheet health report to understand the dynamics of Lotes.TWSE:3533 Discounted Cash Flow as at Mar 2026Taking AdvantageTake a closer look at our Undervalued Asian Stocks Based On Cash Flows list of 228 companies by clicking here.Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.Interested In Other Possibilities?Explore high-performing small cap companies that haven't yet garnered significant analyst attention.Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.  This article by Simply Wall St is general in nature. We provide commentary based on historical data \n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. \n    It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your \n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data. \n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. \n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2622576813","isCrawlerRequest":true}